Fact Sheets: Jardiance & Farxiga
Maryland is working to support affordability through its Prescription Drug Affordability Board (PDAB), while advocates press for the expansion of this authority to help more residents. Among the drugs up for review by the PDAB are Farxiga (dapagliflozin), sold by AstraZeneca, and Jardiance (empagliflozin), sold by Boehringer Ingelheim and Eli Lilly.
Key facts underscore the need to support affordability to these medicines: